http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009018346-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65f6765a6f0387cfcb75bc6a09213161
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-10
filingDate 2008-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cefcb68d6270bd30ba82be8776a2319b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abcdeae73e9ebf36d10f22f4d2a0dd1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2acf7e1c47bd39ba85d2f44eb3787da
publicationDate 2009-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2009018346-A1
titleOfInvention Amorphous Form Of Darifenacin Hydrobromide And Processes For The Preparation Thereof
abstract The present invention relates to amorphous form darifenacin hydrobromide and processes therefor. In addition, the present invention relates to compositions comprising amorphous form darifenacin hydrobromide.
priorityDate 2007-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5096890-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5096890-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6930188-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10006834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453039943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128126220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66879726
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444031
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50878578
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID142807983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135767664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226439188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID142294685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453750595
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44134763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227275170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID142266
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227275397
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226485998
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260

Total number of triples: 44.